Aiming for regulatory approval by July, Institute for Biological Research to develop 15 million doses for Israelis, Palestinians and other possible buyers

Institute for Biological Research to carry out testing in three stages: first on 80 people, then 960 and finally on 30,000 volunteers before it will be cleared for full use

Top official cautions that countries' impulse to vaccinate own citizens before those in poorer countries will only prolong pandemic

FDA says Oxford vaccine testing can resume; other nations already determined participant's illness not related; J&J also finds no link to subject's illness in its trial

Israeli chief medical officer of US biotech firm confirms timeline; separately, hopes raised Israeli-produced shot could be ready in 6 months

Death marks first known fatality in worldwide vaccine trials, independent review concludes no safety concerns and testing can continue

Research conducted in 19 countries finds 14% would refuse inoculation and 14% would hesitate, highlighting need for action to improve public trust

Defense minister says vaccine will be called 'Brilife,' a portmanteau of life and the Hebrew word for health, bri'ut

Pharmaceutical giant has signed an agreement with US government to produce millions of doses even before they are deemed safe and effective

Pharmaceutical giant says if safety data from trials, expected about 2 weeks after US elections, is positive, it will go ahead with request for 'emergency use authorization'